相似文献
1
HOXB13 promotes ovarian cancer progression.
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17093-8. doi: 10.1073/pnas.0707938104. Epub 2007 Oct 17.
2
HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells.
Oncotarget. 2015 May 30;6(15):13359-70. doi: 10.18632/oncotarget.3673.
3
Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.
Mol Cancer Ther. 2018 Dec;17(12):2796-2810. doi: 10.1158/1535-7163.MCT-18-0602. Epub 2018 Sep 21.
4
HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.
J Clin Oncol. 2007 Feb 20;25(6):662-8. doi: 10.1200/JCO.2006.07.3676.
5
Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer.
Carcinogenesis. 2008 Jul;29(7):1459-65. doi: 10.1093/carcin/bgn115. Epub 2008 May 21.
6
The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.
Clin Cancer Res. 2007 Nov 1;13(21):6327-34. doi: 10.1158/1078-0432.CCR-07-0310.
7
Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer.
J Hematol Oncol. 2018 Feb 23;11(1):26. doi: 10.1186/s13045-018-0577-5.
8
Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.
Breast Cancer Res Treat. 2008 Jan;107(2):225-34. doi: 10.1007/s10549-007-9541-8. Epub 2007 Apr 24.
9
HOXB13 networking with ABCG1/EZH2/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients.
Theranostics. 2019 Apr 6;9(7):2084-2099. doi: 10.7150/thno.29463. eCollection 2019.
10
The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
J Clin Oncol. 2006 Oct 1;24(28):4611-9. doi: 10.1200/JCO.2006.06.6944.
引用本文的文献
1
HOXB13 in cancer development: molecular mechanisms and clinical implications.
Front Med. 2025 Mar 11. doi: 10.1007/s11684-024-1119-x.
2
HOXA13 promotes immune evasion in bladder cancer by suppressing antigen processing and presentation, and phagosome pathways.
Funct Integr Genomics. 2025 Feb 24;25(1):44. doi: 10.1007/s10142-025-01553-w.
3
The HOX Gene Family's Role as Prognostic and Diagnostic Biomarkers in Hematological and Solid Tumors.
Cancers (Basel). 2025 Jan 15;17(2):262. doi: 10.3390/cancers17020262.
4
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers.
Breast Cancer Res. 2024 Dec 18;26(1):185. doi: 10.1186/s13058-024-01943-1.
5
Prolonging somatic cell proliferation through constitutive hox gene expression in C. elegans.
Nat Commun. 2023 Oct 27;14(1):6850. doi: 10.1038/s41467-023-42644-1.
6
Differential Protein Expression Patterns of HOXA13 and HOXB13 Are Associated with Bladder Cancer Progression.
Diagnostics (Basel). 2023 Aug 9;13(16):2636. doi: 10.3390/diagnostics13162636.
7
Pan-cancer analysis of Homeobox B9 as a predictor for prognosis and immunotherapy in human tumors.
Aging (Albany NY). 2023 Jun 9;15(11):5096-5124. doi: 10.18632/aging.204785.
8
Variants in , G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men.
Cancer Diagn Progn. 2022 Sep 3;2(5):542-548. doi: 10.21873/cdp.10139. eCollection 2022 Sep-Oct.
9
Comprehensive network analysis of dysregulated genes revealed MNX1-AS1/hsa-miR-4697-3p/HOXB13 axis in ovarian cancer chemotherapy response.
Cancer Sci. 2022 Aug;113(8):2627-2641. doi: 10.1111/cas.15447. Epub 2022 Jun 24.
10
Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer.
Int J Cancer. 2022 Jun 15;150(12):1919-1932. doi: 10.1002/ijc.33949. Epub 2022 Feb 15.
本文引用的文献
1
The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.
Clin Cancer Res. 2007 Nov 1;13(21):6327-34. doi: 10.1158/1078-0432.CCR-07-0310.
2
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients.
Clin Cancer Res. 2007 Jun 15;13(12):3617-22. doi: 10.1158/1078-0432.CCR-06-2878.
3
The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.
J Clin Invest. 2007 May;117(5):1370-80. doi: 10.1172/JCI30866. Epub 2007 Apr 19.
4
Posterior Hox gene expression and differential androgen regulation in the developing and adult rat prostate lobes.
Endocrinology. 2007 Mar;148(3):1235-45. doi: 10.1210/en.2006-1250. Epub 2006 Nov 30.
5
Endocrine regulation of HOX genes.
Endocr Rev. 2006 Jun;27(4):331-55. doi: 10.1210/er.2005-0018. Epub 2006 Apr 21.
6
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.
Cell. 2006 Mar 24;124(6):1283-98. doi: 10.1016/j.cell.2006.01.040.
7
Suppression of invasive characteristics by antisense introduction of overexpressed HOX genes in ovarian cancer cells.
Int J Oncol. 2006 Apr;28(4):931-8.
8
HOXB homeobox gene expression in cervical carcinoma.
Int J Gynecol Cancer. 2006 Jan-Feb;16(1):329-35. doi: 10.1111/j.1525-1438.2006.00350.x.
9
Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
Oncogene. 2006 Mar 16;25(12):1733-42. doi: 10.1038/sj.onc.1209200.
10
Modeling resistance to pathway-targeted therapy in ovarian cancer.
Cell Cycle. 2005 Aug;4(8):1004-6. doi: 10.4161/cc.4.8.1869. Epub 2005 Aug 25.
Zotero 插件